D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 43 Citations 11,937 153 World Ranking 2959 National Ranking 97

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Acquired immunodeficiency syndrome

Internal medicine, Immunology, Drug resistance, Virology and Viral load are his primary areas of study. His Internal medicine research is multidisciplinary, incorporating elements of Nevirapine, Efavirenz and Reverse-transcriptase inhibitor. His Immunology study combines topics from a wide range of disciplines, such as Acquired immunodeficiency syndrome and Confidence interval.

His Drug resistance study incorporates themes from Pharmacology and Drug. His Virology research includes elements of Dolutegravir, Elvitegravir, Raltegravir and Disease progression. His research investigates the connection with Viral load and areas like Surgery which intersect with concerns in Irritability, Adverse effect and Quality of life.

His most cited work include:

  • HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects (470 citations)
  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis (286 citations)
  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study (284 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Virology, Drug resistance, Immunology and Viral load. Roger Paredes interconnects Gastroenterology, Efavirenz, Acquired immunodeficiency syndrome and Reverse-transcriptase inhibitor in the investigation of issues within Internal medicine. He has included themes like Integrase, Raltegravir, Reverse transcriptase and Genotype in his Virology study.

Roger Paredes interconnects Cohort study, Mutation, Intensive care medicine, HIV drug resistance and Genotyping in the investigation of issues within Drug resistance. His Immunology study integrates concerns from other disciplines, such as Microbiome and Confidence interval. In his work, Adverse effect is strongly intertwined with Surgery, which is a subfield of Viral load.

He most often published in these fields:

  • Internal medicine (39.91%)
  • Virology (35.78%)
  • Drug resistance (29.82%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiome (8.26%)
  • Drug resistance (29.82%)
  • Internal medicine (39.91%)

In recent papers he was focusing on the following fields of study:

Roger Paredes mainly focuses on Microbiome, Drug resistance, Internal medicine, Immunology and Virology. His Drug resistance research integrates issues from Integrase, Antiretroviral therapy, Deep sequencing and Bacterial genome size. As a part of the same scientific study, Roger Paredes usually deals with the Deep sequencing, concentrating on Index case and frequently concerns with Genetics.

His Internal medicine research includes elements of Acquired immunodeficiency syndrome and Oncology. Stool specimen is closely connected to Hematopoietic stem cell transplantation in his research, which is encompassed under the umbrella topic of Immunology. His Virology study incorporates themes from Monoclonal antibody and SIGLEC.

Between 2018 and 2021, his most popular works were:

  • Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel (73 citations)
  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. (41 citations)
  • 2019 update of the drug resistance mutations in HIV-1. (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Acquired immunodeficiency syndrome

Roger Paredes mainly investigates Drug resistance, Internal medicine, MEDLINE, Feces and Microbiome. His Drug resistance research includes themes of Computational biology, DNA sequencing and Antiretroviral therapy. When carried out as part of a general Internal medicine research project, his work on Randomized controlled trial is frequently linked to work in Resistance test, therefore connecting diverse disciplines of study.

His research in Feces intersects with topics in Medical microbiology, Akkermansia, Inflammation, CD8 and Bacteriome. His study in Microbiome is interdisciplinary in nature, drawing from both Immune system, Bacteroides and Microbiology. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Integrase, HIV drug resistance, Reverse-transcriptase inhibitor and Transmission.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2011 update of the drug resistance mutations in HIV-1.

V A Johnson;Calvez;H F Gunthard;R Paredes.
Topics in antiviral medicine (2011)

1225 Citations

2017 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2016)

770 Citations

2015 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2015)

758 Citations

2014 Update of the drug resistance mutations in HIV-1.

Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson.
Topics in antiviral medicine (2014)

757 Citations

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve.
Nature Medicine (2010)

598 Citations

2019 update of the drug resistance mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Francesca Ceccherini-Silberstein;Charlotte Charpentier.
Topics in antiviral medicine (2019)

492 Citations

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn.
Lancet Infectious Diseases (2011)

425 Citations

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia.
JAMA (2011)

371 Citations

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

Alison J. Rodger;Rebecca Lodwick;Mauro Schechter;Steven Deeks.
AIDS (2013)

351 Citations

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.

Albert Tuldra;Carmina R. Fumaz;Ma José Ferrer;Ramon Bayes.
Journal of Acquired Immune Deficiency Syndromes (2000)

350 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roger Paredes

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic

Publications: 72

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 66

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 64

Bonaventura Clotet

Bonaventura Clotet

University of Vic

Publications: 63

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 58

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 56

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 53

Anders Sönnerborg

Anders Sönnerborg

Karolinska Institute

Publications: 53

Deenan Pillay

Deenan Pillay

University College London

Publications: 50

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 48

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 46

Caroline Sabin

Caroline Sabin

University College London

Publications: 45

David Dunn

David Dunn

University College London

Publications: 45

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 43

Santiago Moreno

Santiago Moreno

Instituto de Salud Carlos III

Publications: 43

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 42

Something went wrong. Please try again later.